Dallah Healthcare
دله الصحيةTechnical Analysis & Signals
Dallah Healthcare stock is trending downward with strong negative signals.
Technical Analysis
Technical analysis indicates that Dallah Healthcare stock is in a clear downtrend, with the RSI at a low level of 22.7, indicating oversold conditions. Additionally, the MACD crossover suggests continued negative pressure on the stock.
Support & Resistance Levels
The main support level for the stock is at 73.99 SAR, while the nearby resistance level is at 76.21 SAR. The stock is expected to face difficulty in surpassing the resistance level given the current downtrend.
Volume Analysis
The trading volume in the stock may indicate increasing selling pressure, reinforcing the downtrend. If the trading volume continues to rise, it could lead to further price declines.
Fundamental Factors
The stock's P/E ratio is 20.7, which may indicate a relatively high valuation. Additionally, the 2.2% dividend yield may not be attractive under current market conditions.
Risk Factors
Key risks include the current price decline and the potential for continued downtrend. Any negative developments in the Saudi market or the healthcare sector could adversely affect the stock's performance.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Investors are advised to closely monitor market developments before making any investment decisions.
Financial Fundamentals
Price Data
Price Chart - Dallah Healthcare
4004Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Below Lower BandTrend Strength (ADX)
Weak TrendFinancial Summary
Valuation
- Market Cap
- 9.13B
- P/E Ratio
- 20.70
- P/B Ratio
- 2.20
- EPS (Earnings/Share)
- 3.62
Profitability
- Revenue
- 4.29B
- Net Income
- 442.98M
- Return on Equity (ROE)
- +10.30%
- Shares Outstanding
- 121.89M
Balance Sheet
- Total Assets
- 9.14B
- Total Debt
- 4.23B
- Debt/Equity
- 1.02
- Free Float %
- +42.6%
Dividends & Margins
- Dividend Yield
- +2.20%
- Dividend/Share
- 1.67
- Book Value
- 34.05
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
5 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2025 | 4.07B +26.9% | 538.27M +14.2% | 9.14B +38.2% | 3.93B +94.5% | 4.42 +14.2% |
| 2024 | 3.21B +8.9% | 471.20M +30.8% | 6.61B +5.9% | 2.02B +2.5% | 3.87 +31.2% |
| 2023 | 2.94B +18.3% | 360.12M +31.2% | 6.24B +26.9% | 1.97B -0.2% | 2.95 +31.1% |
| 2022 | 2.49B | 274.46M | 4.92B | 1.98B | 2.25 |
| 2021 | — | — | — | — | — |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
No news currently available for Dallah Healthcare
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 227.50 SAR | |
| 4002 | Mouwasat | 63.90 SAR | |
| 4004 | Dallah Healthcare | 74.90 SAR | |
| 4017 | Fakeeh Care | 36.30 SAR | |
| 4005 | CARE | 115.00 SAR | |
| 4018 | Almoosa | 115.80 SAR | |
| 4019 | SMC Healthcare | 15.86 SAR | |
| 4007 | Alhammadi | 22.86 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-09-22
Risk Assessment
Risk Factors
Average True Range 2.3% of stock price
Trading volume near or above average
P/E ratio 20.7
Debt-to-equity ratio 1.02
ADX indicator at 20 — no clear direction
Very high volatility or severe financial pressures requiring extreme caution
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is Dallah Healthcare stock price today?
Dallah Healthcare (4004) stock price today is 74.90 SAR, declining by -1.32% compared to the previous session close. The 52-week price range is between 73.99 SAR and 128.87 SAR.
2 What is Dallah Healthcare stock valuation?
The automated analysis signal for Dallah Healthcare is "Strong Sell" with 85% confidence. The P/E ratio is 20.7. The P/B ratio is 2.20.
3 Is Dallah Healthcare Shariah-compliant?
Yes, Dallah Healthcare (4004) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are Dallah Healthcare dividend distributions?
Dallah Healthcare has a dividend yield of 2.20%, with an estimated annual dividend of 1.67 SAR per share.
5 What is Dallah Healthcare weekly performance?
Dallah Healthcare performance over different time periods: weekly change -6.37%, monthly -11.88%, and year-to-date -27.23%. The stock is currently trading with a volume of 163,711 shares.
6 What is the target level for Dallah Healthcare?
According to automated analysis for Dallah Healthcare: Short-term target (1-2 weeks): 72.00 SAR. Support level: 73.99 SAR. Resistance level: 76.21 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.